Tesamorelin Dosage Calculator

Last updated: 2026-11-10

Sources checked: 2026-11-10

📌At a Glance: Tesamorelin Reconstitution Arithmetic

FDA-Approved Formulation: Tesamorelin is FDA-approved under the brand names Egrifta and Egrifta SV. The approved commercial product is supplied as a lyophilized powder with an official reconstitution protocol.
Official Label Instruction Governs: If you possess the prescription FDA-approved product, follow the official package insert instructions (reconstituting with the provided Sterile Water for Injection, not multi-dose bacteriostatic water).
Label vs. Naive Math: Official single-dose vials are formulated with specific overfills (e.g. Egrifta SV 2 mg reconstituted with 0.42 mL diluent yields 4 mg/mL to deliver 1.4 mg in 0.35 mL). On prescription products, the label's delivered concentration governs over raw vial arithmetic.
Syringe Calibration: All volumetric conversions assume a standard U-100 insulin syringe (100 units = 1.0 mL, or 0.01 mL per unit graduation mark).

⚖️Regulatory & Compound Status

Verified: 2026-11-10

Tesamorelin is FDA-approved under the proprietary names Egrifta (1 mg/vial) and Egrifta SV (2 mg/vial) as an injectable growth hormone-releasing hormone (GHRH) analogue indicated exclusively for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy. The approved product is supplied as a lyophilized powder requiring reconstitution with sterile diluent immediately prior to subcutaneous administration. Unapproved lyophilized vials marketed online as 'research chemicals' lack FDA approval, prescription packaging, and sterile diluent kits.

Official Sources:Egrifta (tesamorelin for injection) Prescribing Information,Safety Risks Associated with Certain Bulk Drug Substances Nominated for 503A/503B Compounding

ℹ️What This Tool Cannot Tell You

This calculator cannot provide medical advice, diagnosis, or clinical prescription guidance.
It cannot alter or supersede the official FDA package insert instructions for prescription Egrifta.
It cannot verify the chemical purity, sterility, or peptide content of unapproved research vials.
It cannot guarantee solution stability beyond documented USP <797> multi-dose preservative limits.

This tool converts volumetric liquid measurements and syringe tick marks only. It does not provide medical guidance, dosing schedules, or clinical administration protocols. Review our Medical & Research Disclaimer.

What Is Tesamorelin Reconstitution Arithmetic?

Tesamorelin is a synthetic 44-amino-acid peptide analogue of human growth hormone-releasing factor (GRF / GHRH). It incorporates an N-terminal trans-3-hexenoyl fatty-acid moiety attached to the tyrosine residue at position 1. This acyl chain modification confers resistance to enzymatic degradation by dipeptidyl peptidase-4 (DPP-4), prolonging its biological half-life compared to endogenous native GHRH while preserving selective binding to pituitary GHRH receptors.

Unlike most research peptides that exist solely as unregulated chemicals, tesamorelin exists in two parallel forms: the FDA-approved pharmaceutical product (Egrifta) and freeze-dried lyophilized powder vials sold in academic research channels. Reconstitution is the chemical dissolution of this lyophilized cake using sterile diluent. Our tesamorelin dosage calculator provides deterministic mathematical conversions across standard research vial masses (2 mg, 5 mg, 10 mg) and contrasts them with official prescription label specifications.

Tesamorelin Dosage Chart

This reference chart translates intended milligram test masses into volumetric draw units on a standard U-100 syringe across 2 mg, 5 mg, and 10 mg research vials. These figures represent illustrative mathematical conversions across uniform benchmark test amounts (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg) and do not represent medical advice, clinical protocols, or therapeutic recommendations.

Vial Size	Bac Water Added	Concentration	Example Amount	Draw Units (U-100)
2 mg	1.0 mL	2.0 mg/mL	0.5 mg	25.0 Units
2 mg	1.0 mL	2.0 mg/mL	1.0 mg	50.0 Units
2 mg	2.0 mL	1.0 mg/mL	0.5 mg	50.0 Units
5 mg	2.0 mL	2.5 mg/mL	1.0 mg	40.0 Units
10 mg	2.0 mL	5.0 mg/mL	1.0 mg	20.0 Units
10 mg	2.0 mL	5.0 mg/mL	2.0 mg	40.0 Units
10 mg	3.0 mL	3.33 mg/mL	1.0 mg	30.0 Units

Tesamorelin Vial Size and Diluent Conversion Matrix

The table below outlines resulting solution concentrations, unit potencies, and draw units required per 1.0 mg across standard research vials (2 mg, 5 mg, 10 mg) and diluent volumes (1 mL, 2 mL, 3 mL). For comparison, the official pharmaceutical presentation (Egrifta SV 2 mg with 0.42 mL diluent) is included to illustrate pharmaceutical concentration dynamics.

Vial Setup	Diluent Added	Concentration (mg/mL)	Potency per Unit (mcg/U)	Units per 1.0 mg Draw
2 mg Research Vial	1.0 mL	2.00 mg/mL	20.0 mcg/U	50.0 Units
2 mg Research Vial	2.0 mL	1.00 mg/mL	10.0 mcg/U	100.0 Units
5 mg Research Vial	1.0 mL	5.00 mg/mL	50.0 mcg/U	20.0 Units
5 mg Research Vial	2.0 mL	2.50 mg/mL	25.0 mcg/U	40.0 Units
5 mg Research Vial	3.0 mL	1.67 mg/mL	16.7 mcg/U	60.0 Units
10 mg Research Vial	1.0 mL	10.00 mg/mL	100.0 mcg/U	10.0 Units
10 mg Research Vial	2.0 mL	5.00 mg/mL	50.0 mcg/U	20.0 Units
10 mg Research Vial	3.0 mL	3.33 mg/mL	33.3 mcg/U	30.0 Units
Egrifta SV (Prescription)	0.42 mL	4.00 mg/mL	40.0 mcg/U	25.0 Units

Worked Calculation Example: 2 mg Vial with 1.0 mL vs. 2.0 mL Diluent

Example Parameters:

Vial Mass: 2.0 mg solid lyophilized cake
Target Test Amount: 0.5 mg (500 mcg) illustrative calculation
Syringe Standard: U-100 insulin syringe (100 units = 1.0 mL, or 0.01 mL per unit)
Diluent Comparisons: 1.0 mL vs. 2.0 mL Bacteriostatic Water

Step-by-Step Calculation:

Option A (1.0 mL Diluent): Determine concentration = 2.0 mg ÷ 1.0 mL = 2.0 mg/mL (2,000 mcg/mL).
Option A Draw Volume: Volumetric draw = 0.5 mg ÷ 2.0 mg/mL = 0.25 mL.
Option A Syringe Units: 0.25 mL × 100 units/mL = 25.0 Units on a U-100 syringe.
Option B (2.0 mL Diluent): Determine concentration = 2.0 mg ÷ 2.0 mL = 1.0 mg/mL (1,000 mcg/mL).
Option B Draw Volume: Volumetric draw = 0.5 mg ÷ 1.0 mg/mL = 0.50 mL.
Option B Syringe Units: 0.50 mL × 100 units/mL = 50.0 Units on a U-100 syringe.
Mathematical Back-Check (Option A): 25.0 units × 0.01 mL/unit = 0.25 mL. 0.25 mL × 2.0 mg/mL = 0.5 mg. Result confirms target mass.
Mathematical Back-Check (Option B): 50.0 units × 0.01 mL/unit = 0.50 mL. 0.50 mL × 1.0 mg/mL = 0.5 mg. Result confirms target mass.

Result:

Adding 1.0 mL yields a 25-unit draw for 0.5 mg; adding 2.0 mL yields a 50-unit draw for 0.5 mg.

Note: Both options deliver the exact same 0.5 mg mass of tesamorelin. Option A keeps the injection volume compact (0.25 mL), whereas Option B expands it to a half-milliliter.

If You Possess the FDA-Approved Product, the Official Label Governs

Tesamorelin occupies a unique position in peptide mathematics: unlike compounds that exist exclusively as research chemicals, tesamorelin is an FDA-approved drug with an official prescribing insert (DailyMed / Egrifta SV). This creates two distinct mathematical contexts:

1. Prescription Label vs. Naive Arithmetic:
• The commercial drug Egrifta SV is supplied as a 2 mg lyophilized cake accompanied by single-use ampules of Sterile Water for Injection (USP).
• The official FDA instructions direct the user to reconstitute with 0.42 mL of Sterile Water for Injection. The reconstituted solution achieves a concentration of 4 mg/mL, from which 0.35 mL is injected to deliver 1.4 mg of tesamorelin.
• Why does 2 mg in 0.42 mL equal 4 mg/mL? Because pharmaceutical manufacturing accounts for powder displacement volume and factory overfill designed to ensure complete extractable volume. On FDA-approved products, the label's stated concentration always governs over theoretical arithmetic.

2. Diluent Chemistry Disconnect:
• The approved Egrifta product specifically mandates single-use unpreserved Sterile Water for Injection, intended for immediate administration with leftover liquid discarded.
• By contrast, multi-dose vials using bacteriostatic water (containing 0.9% benzyl alcohol) are subject to a 28-day post-puncture discard window under FDA multi-dose sterile vial guidance. Never assume instructions between prescription single-use kits and multi-dose vials are interchangeable.

For a step-by-step primer on handling dilution calculations, consult our tutorial on how to calculate peptide dosage.

Tesamorelin Chemical Stability & Laboratory Handling

Tesamorelin's 44-amino-acid peptide chain is vulnerable to mechanical shear stress and thermal degradation. When adding diluent, aim the needle against the inner glass wall so the fluid flows down smoothly, avoiding high-velocity stream impact directly onto the lyophilized cake. Roll or swirl the vial gently until the cake completely dissolves into a clear, colorless liquid. Do not shake vigorously.

Store reconstituted solutions upright in continuous refrigeration between 2°C and 8°C (USP <659>) and protect from direct light exposure. Under FDA multi-dose sterile vial guidance and USP <797> standards, multi-dose vials preserved with 0.9% benzyl alcohol should be discarded 28 days after initial puncture unless product labeling specifies a shorter limit. Never freeze liquid reconstituted peptide solutions. For complete standard operating procedures, review our step-by-step guide on how to reconstitute peptides safely.

Common Calculation & Measurement Mistakes

⚠️Applying Generic Research Math to Prescription Egrifta

Patients holding prescription Egrifta SV must follow the package insert (0.42 mL diluent delivering 1.4 mg in 0.35 mL). Applying generic 2.0 mL online reconstitution assumptions will dilute prescription medication by nearly five-fold.

⚠️Assuming Bacteriostatic Water Is Required for Single-Use Vials

Prescription Egrifta is packaged with unpreserved Sterile Water for Injection because each vial is designed for immediate single administration. Adding bacteriostatic water to single-use pharmaceutical kits contradicts approved labeling.

⚠️Ignoring Powder Displacement and Overfill

Lyophilized cakes occupy physical volume. In high-precision pharmaceutical formulations, the final solution volume is slightly larger than the volume of liquid introduced. On commercial products, rely on the label's delivered concentration rather than raw division.

⚠️Using a U-40 Syringe for U-100 Calculations

U-100 syringes contain 100 units per mL (0.01 mL/unit). U-40 veterinary syringes contain 40 units per mL (0.025 mL/unit). Drawing 25 units on a U-40 syringe delivers 0.625 mL instead of 0.25 mL—causing an unintentional 2.5× volumetric error.

Comparing Tesamorelin with Growth Hormone Secretagogues

Tesamorelin belongs to the growth-hormone-releasing hormone (GHRH) class of peptides. Understanding how its structural characteristics and arithmetic compare to related secretagogues clarifies laboratory calculations:

• Compared to Sermorelin: Sermorelin represents the truncated 29-amino-acid bioactive N-terminal sequence of human GHRH (GHRH 1-29 amide). Tesamorelin is a synthetic analogue of the complete 44-amino-acid GHRH sequence stabilized by an N-terminal trans-3-hexenoyl fatty-acid group. Sermorelin research vials typically come in 3 mg or 6 mg sizes, whereas tesamorelin vials range from 2 mg up to 10 mg.
• Compared to CJC-1295 & Ipamorelin Blend: CJC-1295 is a modified GHRH peptide (Tetrasubstituted GRF 1-29) often paired with ipamorelin (a ghrelin mimetic). In dual-peptide blend vials, each compound maintains an independent concentration requiring blend math.
• Compared to MOTS-c: MOTS-c is a mitochondrial-derived peptide operating on metabolic pathways rather than pituitary GHRH receptors, typically packaged in larger 10 mg to 40 mg vials.

Reconstitution Protocol Summary

Lyophilized tesamorelin dissolves cleanly when diluent is introduced gently under sterile conditions.

Syringe Reading Diagram

U-100 Syringe Graduation & Measurement Line (Tesamorelin)

Standard Reconstitution Protocol

Follow our standardized 5-step sterile reconstitution guide for full vial preparation, alcohol disinfection, and needle handling SOPs.

Universal Step-by-Step Reconstitution Guide→

❄️ Storage & Shelf-Life Notice (Tesamorelin)

Store reconstituted tesamorelin solutions refrigerated at 2°C–8°C (36°F–46°F). Never freeze reconstituted liquid solutions.

⚠️ Common Preparation Mistakes to Avoid

Common errors include using generic online calculator numbers for prescription Egrifta, shaking the vial violently, and confusing U-40 with U-100 syringes.

Tesamorelin Dosing FAQ

Does the FDA-approved tesamorelin product use bacteriostatic water?↓

No. Official FDA labeling for Egrifta and Egrifta SV specifies reconstitution with unpreserved Sterile Water for Injection (SWFI) provided in the commercial kit. Each reconstituted vial is for immediate single use, and any unused liquid must be discarded. Multi-dose bacteriostatic water is used primarily in research settings.

Why does the official Egrifta label concentration differ from basic math?↓

Pharmaceutical manufacturers incorporate precise powder overfill and account for lyophilized cake displacement volume to guarantee that exactly 1.4 mg can be withdrawn in 0.35 mL. When using approved medications, the delivered concentration stated on the package insert always governs over naive division.

How does tesamorelin compare structurally to sermorelin?↓

Sermorelin is a 29-amino-acid truncated peptide corresponding to the functional N-terminal fragment of native human GHRH. Tesamorelin is a synthetic 44-amino-acid peptide encompassing the full native GHRH sequence with an N-terminal trans-3-hexenoyl fatty-acid modification that confers resistance to DPP-4 cleavage.

What syringe standard should be used for measuring tesamorelin draws?↓

Calculations on this page are calibrated for standard U-100 insulin syringes (100 units = 1.0 mL, or 0.01 mL per unit). For small draws of 25 to 50 units (0.25 mL to 0.50 mL), a 0.3 mL or 0.5 mL U-100 syringe provides the highest graduation readability.

Can reconstituted tesamorelin liquid be stored in the freezer?↓

No. Reconstituted peptide solutions must never be frozen. Ice crystal formation can disrupt the secondary and tertiary peptide structure, leading to aggregation and loss of potency. Store liquid reconstituted vials refrigerated at 2°C–8°C.

Related Peptide Calculators & Stacks

CJC-1295 & Ipamorelin

Calculate CJC-1295 + Ipamorelin stack reconstitution, GHRH/GHRP secretagogue math, and syringe units.

Calculate CJC-1295 & Ipamorelin→

MOTS-c

Calculate reconstitution volume, solution concentration, and U-100 syringe units for research MOTS-c vials.

Calculate MOTS-c→

Sermorelin

Calculate Sermorelin GHRH analogue reconstitution, microgram dosing, and U-100 syringe units.

Calculate Sermorelin→

Related Reconstitution & Dosing Guides

View All FAQs→

MOTS-c FAQ

How to Reconstitute MOTS-c?

→

General Peptide FAQ

How to Reconstitute Peptides?

→